期刊文献+

心房颤动的抗栓塞治疗 被引量:4

下载PDF
导出
摘要 颤动(房颤)是临床最常见的快速性心律失常,其发作时患者出现心悸等症状,大大降低影响生活质量.更加严重的是,房颤可诱发或加重心力衰竭,增加血栓栓塞的并发症5~7倍,显著增加患者的致残率和致死率.多个大型临床试验结果均表明,房颤是器质性心脏病患者病死率增高的独立危险因子之一.发生房颤的主要危险因素有年龄、高血压、心肌梗死、充血性心力衰竭和风湿性心脏病.因此,随着人口的老龄化及心肌梗死后和慢性心力衰竭生存率的改善,房颤正在成为公共健康的主要问题.
作者 王丹
机构地区 中国人民解放军
出处 《中国医药指南》 2012年第4期72-74,共3页 Guide of China Medicine
  • 相关文献

同被引文献30

  • 1刘松年,荆凌华,李兰英.华法林预防老年非瓣膜病慢性心房颤动患者缺血性脑卒中的临床研究[J].国外医学(内科学分册),2006,33(5):229-230. 被引量:13
  • 2叶任高,主编.内科学[M]第6版.北京:人民卫生出版社,2005.57.
  • 3Fuster V, Rydrn LE, Cannom DS, et al. ACC,/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelinesand the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) : developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society [ J 1. Circulation, 2006, 114 ( 3 ) : e257- e354.
  • 4Wallentin L, Ezekowite M, Sinmer TA, et al. PETRO inves- tigators Safety and efficacy of a new oral direct thromb in inhibi- tor dabigatan in atrial fibrillation a dose finding trail with compar- ison to warfarin [J]. EurHeartJ, 2005, 26 (suppl): 484.
  • 5郝长生,陈颖敏.老年心房颤动患者华法林治疗的效果与风险[J].中国心电起搏与心电生理杂志,20lO,24(3):260-262.
  • 6Heeringa J, van der Kuip D A, Hofman A, et al. Prevalence,inci- dence and lifetime risk of atrial fibrillation: the Rottendam study[J]. Eur Heart J, 2006, 27:949-953.
  • 7Connolly S J, Ezekowitz M D, Yusuf S, et al. Dabigatran versus warfarin in in patients with atrial fibrillation[J]. N Engl Jmed, 2009, 361(12):1139-1151.
  • 8Furberg C D, Psaty B M, Manolio T A, et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)[J]. Am J Cardiol, 1994, 74(3): 236-241.
  • 9Craig T, January F, Samuel W, et al. 2014 AHA/ACC/HRS Guide- line for the Management of Patients With Atrial Fibrillation [J]. J Am Cell Cardiol, 2014,26: S0735-1097(14)01739-2.
  • 10Patel M R, Mahaffey K W, Garg J, et al. Rivaroxahan versus war- farin in nonvalvular atrial fibrillation[J]. N Engl J Med, 2011, 365: 883-891.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部